Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -59.60%71.2M | -28.09%532.24M | -48.53%73.04M | -55.86%111.54M | -31.52%125.65M | 8.76%176.24M | -5.59%740.14M | 141.91M | 48.83%252.71M | 183.47M |
| Cost of revenue | -28.18%518.83M | -5.75%722.46M | ||||||||
| Gross profit | -24.20%13.4M | 1.28%17.68M | ||||||||
| Operating expense | -58.95%75.38M | 39.66%27.82M | -50.48%76.19M | -53.75%116.39M | -31.99%125.13M | 16.59%183.64M | -70.08%19.92M | 153.87M | 44.42%251.62M | 183.99M |
| Selling and administrative expenses | ---- | -34.89%32.33M | ---- | ---- | ---- | ---- | -33.76%49.65M | ---- | ---- | ---- |
| -Selling and marketing expense | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| -General and administrative expense | ---- | -34.89%32.33M | ---- | ---- | ---- | ---- | -31.45%49.65M | ---- | ---- | ---- |
| Depreciation and amortization | 52.31%792K | 11.21%3.11M | 2,019.35%657K | -55.02%318K | -39.55%486K | -58.43%520K | --2.79M | --31K | -69.77%707K | --804K |
| -Depreciation | 52.31%792K | 11.21%3.11M | 2,019.35%657K | -55.02%318K | -39.55%486K | -58.43%520K | --2.79M | --31K | -69.77%707K | --804K |
| Other operating expenses | -59.16%74.79M | -29.49%550.19M | -54.34%79.92M | -53.89%116.37M | -31.19%126.47M | 8.28%183.12M | --780.32M | --175.03M | 35.00%252.37M | --183.8M |
| Total other operating income | --202K | -84.83%4.51M | -79.29%4.39M | -79.22%304K | 201.16%1.82M | ---- | 254.62%29.74M | --21.19M | -90.29%1.46M | --605K |
| Operating profit | 43.56%-4.18M | -544.97%-14.42M | 73.66%-3.15M | -544.94%-4.84M | 198.65%513K | -263.07%-7.4M | 95.45%-2.24M | -11.96M | 124.55%1.09M | -520K |
| Net non-operating interest income (expenses) | 46.05%-41K | 68.83%-288K | -253.33%-23K | 75.47%-65K | 72.73%-90K | 77.91%-76K | 36.01%-924K | 15K | 25.56%-265K | -330K |
| Non-operating interest income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --15K | ---- | ---- |
| Non-operating interest expense | -46.05%41K | -75.72%169K | 253.33%23K | -75.47%65K | -72.73%90K | -77.91%76K | -51.80%696K | ---15K | -25.56%265K | --330K |
| Total other finance cost | ---- | -47.81%119K | ---- | ---- | ---- | ---- | --228K | ---- | ---- | ---- |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 0 | 0 | 0 | |||||||
| Income from associates and other participating interests | -37K | -438.24%-345K | -137.86%-333K | 0 | 0 | 0 | 120.61%102K | -140K | -3K | 500K |
| Special income (charges) | -8.61%923K | 1.01M | ||||||||
| Less:Write off | ---- | 8.61%-923K | ---- | ---- | ---- | ---- | ---1.01M | ---- | ---- | ---- |
| Other non-operating income (expenses) | 64.49%-2M | 52.25%-5.63M | ||||||||
| Income before tax | 43.09%-4.25M | -110.03%-16.12M | 70.99%-3.51M | -698.29%-4.91M | 220.86%423K | -289.81%-7.47M | 87.78%-7.68M | -12.08M | 117.13%820K | -350K |
| Income tax | -5K | -90.20%67K | -91.42%57K | -50.00%10K | 0 | 0 | 432.04%684K | 664K | 110.31%20K | 0 |
| Net income | 43.16%-4.25M | -93.65%-16.19M | 72.05%-3.56M | -714.50%-4.92M | 220.86%423K | -289.81%-7.47M | 86.65%-8.36M | -12.75M | 117.41%800K | -350K |
| Net income continuous operations | 43.16%-4.25M | -93.65%-16.19M | 72.05%-3.56M | -714.50%-4.92M | 220.86%423K | -289.81%-7.47M | 86.65%-8.36M | ---12.75M | 117.41%800K | ---350K |
| Noncontrolling interests | -1K | -5K | 0 | 0 | 0 | 0 | 58K | -242.86%-20K | 0 | |
| Net income attributable to the company | 43.17%-4.25M | -93.59%-16.19M | 72.18%-3.56M | -699.51%-4.92M | 220.86%423K | -288.00%-7.47M | 86.61%-8.36M | -12.81M | 117.80%820K | -350K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 43.17%-4.25M | -93.59%-16.19M | 72.18%-3.56M | -699.51%-4.92M | 220.86%423K | -288.00%-7.47M | 86.61%-8.36M | -12.81M | 117.80%820K | -350K |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 57.50%-0.0017 | -76.19%-0.74 | 75.00%-0.0016 | -700.00%-0.0024 | 214.29%0.0002 | -300.00%-0.004 | 88.68%-0.42 | -0.0064 | 106.67%0.0004 | -0.0002 |
| Diluted earnings per share | 57.50%-0.0017 | -76.19%-0.74 | 75.00%-0.0016 | -700.00%-0.0024 | 214.29%0.0002 | -300.00%-0.004 | 88.68%-0.42 | -0.0064 | 106.67%0.0004 | -0.0002 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.